Merit Medical Systems Inc. (MMSI) intrinsic value & 10-year financials

Merit Medical Systems Inc. (MMSI) has a Graham intrinsic value of $70.75 per share. At $89.20 on Oct 17, 2026, the stock trades 26% above that value. Over the last 10 fiscal years revenue grew 10.8% a year to $1.5B, with an average return on invested capital of 4.5%.

Graham intrinsic value
$70.75
Share price (Oct 17, 2026)
$89.20
Price vs Graham value
26% above
Market cap
$5.4B
Revenue (FY2025)
$1.5B
Revenue growth (10-yr CAGR)
10.8%
ROIC (10-yr avg)
4.5%
Free cash flow (FY2025)
$215.7M

MMSI 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $1.5B $128.5M $2.13 $215.7M 12.2% 7.4%
FY2024 $1.4B $120.4M $2.03 $185.7M 11.5% 7.6%
FY2023 $1.3B $94.4M $1.62 $110.9M 9.9% 7.4%
FY2022 $1.2B $74.5M $1.29 $69.3M 7.6% 6.0%
FY2021 $1.1B $48.5M $0.84 $119.3M 5.7% 4.2%
FY2020 $963.9M -$9.8M -$0.18 $119.3M -0.2% -0.1%
FY2019 $994.9M $5.5M $0.10 -$360.0K 1.6% 1.2%
FY2018 $882.8M $42.0M $0.78 $23.2M 6.6% 4.6%
FY2017 $727.9M $27.5M $0.55 $24.1M 4.5% 2.9%
FY2016 $603.8M $20.1M $0.45 $20.8M 5.8% 3.4%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

MERIT MEDICAL SYSTEMS INC is a consistent compounder, expanding top-line revenue at 10.8% annually over the past decade.

MERIT MEDICAL SYSTEMS INC has historically struggled to out-earn its cost of capital, averaging just 4.5% ROIC.

MERIT MEDICAL SYSTEMS INC has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, MERIT MEDICAL SYSTEMS INC is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $70.75 per share.

MMSI stock: frequently asked questions

What is the intrinsic value of Merit Medical Systems Inc. (MMSI) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, MMSI's intrinsic value is about $70.75 per share.

Is MMSI stock undervalued?

At $89.20 (close on Oct 17, 2026), MMSI trades 26% above its Graham value of $70.75. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Merit Medical Systems Inc. grown?

Revenue went from $603.8M in fiscal 2016 to $1.5B in fiscal 2025, a compound annual growth rate of 10.8%. Net income was $128.5M in fiscal 2025.

Does Merit Medical Systems Inc. generate free cash flow?

Merit Medical Systems Inc. generated $215.7M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 9 of the last 10 reported years.

What is MMSI's return on invested capital?

Average ROIC over the last 10 fiscal years was 4.5%, and average return on equity was 5.1%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this MMSI data come from?

From Merit Medical Systems Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Jul 30, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks